Key result
The discovery and characterization of thrombopoietin (c-Mpl ligand) as the humoral regulator of platelet production was achieved simultaneously by multiple laboratories in 1994.
Answers are grounded in this paper and cite their sources.
This editorial discusses the historical discovery and characterization of thrombopoietin.
For approximately 30 years, hematologists have sought the humoral regulator of platelet production, thrombopoietin.1 Although a factor with the appropriate physiologic effects was partially purified, the goal continued to evade researchers until 1994, when three laboratories simultaneously reported that c-Mpl ligand had the characteristics of thrombopoietin.2 Synonyms for thrombopoietin in the literature are c-Mpl ligand, mpl ligand, megapoietin, and megakaryocyte growth and development factor (a truncated version of thrombopoietin).What explains the fact that thrombopoietin was ultimately purified and characterized by five laboratories almost simultaneously? In 1992, Wendling and colleagues described the c-mpl gene, the cellular homologue of v- . . .
No takes yet. Share an insight, caveat, or question.
Jack Levin (1997) reported an editorial. Thrombopoietin was evaluated. The discovery and characterization of thrombopoietin (c-Mpl ligand) as the humoral regulator of platelet production was achieved simultaneously by multiple laboratories in 1994.
Synapse has enriched 10 related papers. Consider them for comparative context: